Elsevier

Biochemical Pharmacology

Volume 45, Issue 5, 9 March 1993, Pages 1065-1077
Biochemical Pharmacology

Initial characterization of the major mouse cytochrome p450 enzymes involved in the reductive metabolism of the hypoxic cytotoxin 3-Amino-1,2,4-Benzotriazine-1,4-di-N-Oxide (Tirapazamine, SR 4233, Win 59075)

https://doi.org/10.1016/0006-2952(93)90251-QGet rights and content

Abstract

The benzotriazine di-N-oxide SR4233 (tirapazamine, WIN 59075) is currently in phase I clinical trials as the lead compound in a series of novel and highly selective antitumour hypoxic cytotoxins. Reductive bioactivation is thought to proceed via a one-electron reduced, oxidizing nitroxide radical and also forms the inactive single N-oxide SR4317 via radical disproportionation or a second oneelectron reduction. In mouse liver microsomes reductive metabolism is catalysed predominantly by cytochrome P450 (70%) and cytochrome P450 reductase (30%). The aim of the present study was to examine which cytochrome P450 isozymes may be involved. Reduction of SR4233 to SR4317 was monitored by HPLC analysis. Metabolism by microsomes from both control and dexamethasone-induced BALB/c male mice was 70% inhibited by carbon monoxide. The cytochrome P450 inhibitor SKF 525A, following aerobic preincubation, also inhibited SR4233 reduction by 58%. Reduction was induced 2–3-fold by dexamethasone and was not accountable by increases in cytochrome P450 reductase or DT-diaphorase. The induction data and the greater degree of inhibition of SR 4233 reduction by metyrapone compared to α-naphthoflavone suggested a possible involvement of Cyp2b, Cyp2c and Cyp3a cytochrome P450 subfamilies. Both Cyp3a (7.4-fold) and Cyp2b (1.8-fold) type enzymes were shown by western immunoblot analysis to be induced by dexamethasone, the latter correlating more closely with increased SR 4233 reductase activity and also with the 2-fold induction of benzphetamine TV-demethylase, a Cyp2b-type enzyme. No inhibition of SR4233 reduction was seen with erythromycin or cyclosporin A which act as substrates/inhibitors for Cyp3a-type enzymes, but inhibition was seen with p-nitrophenol and tolbutamide which are substrates for Cyp2el- and Cyp2c-type enzymes, respectively (11% and 25% inhibition in induced microsomes). SR4233 itself inhibited benzphetamine N-demethylase, which is catalysed by Cyp2b-type enzymes but not erythromycin N-demethylase which is catalysed by Cyp3a-type isoforms. Immunoinhibition studies with epitope specific monoclonal antibodies were consistent with the major involvement of phenobarbitone- and steroid-inducible products of the Cyp2b and Cyp2c subfamilies. These forms contributed at least 53% and 26%, respectively, of the cytochrome P450-associated SR4233 reductase activity in the induced microsomes. The findings support our earlier conclusion that cytochrome P450 is the major SR 4233 reductase in mouse liver and provides leads as to the possible involvement of specific isoforms in human tumours and normal tissues.

References (68)

  • T Omura et al.

    The carbon monoxide-binding pigment of liver microsomes. 1. Evidence for its hemoprotein nature

    J Biol Chem

    (1964)
  • MM Bradford

    A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

    Anal Biochem

    (1976)
  • Y Yasukochi et al.

    Some properties of a detergent-solubilized NADPH-cytochrome c (cytochrome P-450) reductase purified by biospecific affinity chromatography

    J Biol Chem

    (1976)
  • L Ernster

    DT-diaphorase

    Methods Enzymol

    (1967)
  • MI Walton et al.

    A high-performance liquid chromatography assay for the novel hypoxic cell cytotoxin benzotriazine di-N-oxide (SR 4233) and its reduced metabolites in biological materials

    J Chromatogr

    (1988)
  • F Heubel et al.

    Differences between induction effects of 1,4-bis [2-(3,5-dichloropyridyloxy)] benzene and phenobarbitone

    Biochem Pharmacol

    (1989)
  • E Albano et al.

    Role of ethanol-inducible cytochrome P450 (P450IIE1) in catalysing the free radical activation of aliphatic alcohols

    Biochem Pharmacol

    (1991)
  • H Raunio et al.

    Immunochemical detection of human liver cytochrome P450 forms related to phenobarbital-inducible forms in the mouse

    Biochem Pharmacol

    (1990)
  • C Lind et al.

    DT-diaphorase: purification, properties and function

    Methods Enzymol

    (1990)
  • J Maenpaa et al.

    Comparative studies on coumarin and testosterone metabolism in mouse and human livers. Differential inhibitions by the anti-P450Coh antibody and metyrapone

    Biochem Pharmacol

    (1991)
  • E Maser et al.

    Purification and properties of a metyrapone-reducing enzyme from mouse liver microsomes—this ketone is reduced by an aldehyde reductase

    Biochem Pharmacol

    (1989)
  • E Maser et al.

    Carbonyl reduction of metyrapone in human liver

    Biochem Pharmacol

    (1991)
  • KM Kedzie et al.

    Molecular basis for a functionally unique cytochrome P450IIB1 variant

    J Biol Chem

    (1991)
  • MI Walton et al.

    Nitroimidazole bioreductive metabolism: quantitation and characterization of mouse tissue benznidazole nitroreductases in vivo and in vitro

    Biochem Pharmacol

    (1987)
  • AR Goeptar et al.

    One-electron reductive bioactivation of 2,3,5,6-tetramethyl-benzoquinone by cytochrome P450

    Biochem Pharmacol

    (1992)
  • FK Friedman et al.

    Induction of rat liver microsomal and nuclear cytochrome P-450 by dietary 2-acetylaminofluorene and butylate hydroxy toluene

    Biochem Pharmacol

    (1989)
  • P Workman

    Bioreductive mechanisms

    Int J Radiat Oncol Biol Phys

    (1992)
  • A Cahill et al.

    Reductive metabolism of 3-amino-1,2,4-benzotriazine-1,4-dioxide (SR 4233) and the induction of unscheduled DNA synthesis in rat and human derived cell lines

    Carcinogenesis

    (1990)
  • KA Beidermann et al.

    SR 4233 cytotoxicity and metabolism in DNA repaircompetent and repair-deficient cell cultures

    Br J Cancer

    (1991)
  • RV Lloyd et al.

    Microsomal reduction of 3-amino-1,2,4-benzotriazine 1,4-dioxide to a free radical

    Mol Pharmacol

    (1991)
  • MA Baker et al.

    Metabolism of SR 4233 by Chinese hamster ovary cells: basis of selective hypoxic cytotoxicity

    Cancer Res

    (1988)
  • AK Costa et al.

    In vitro hepatotoxicity of SR 4233 (3-amino-1,2,4-benzotriazine-1,4-oxide), a hypoxic cytotoxin and potential antitumour agent

    Cancer Res

    (1989)
  • H Kappus

    Oxidative stress in chemical toxicity

    Arch Toxicol

    (1987)
  • L Ernster

    DT-diaphorase: a historical review

    Chem Scripta

    (1987)
  • Cited by (0)

    Present address: Fisons Pharmaceuticals Research and Development Laboratories, Biochemistry Division, Drug Metabolism Section, Bakewell Road, Loughborough, Leicestershire LE11 0RH, U.K.

    View full text